#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Primary hyperoxaluria Neuroendocrine carcinoma SAPHO syndrome Keratosis follicular Congenital leptin deficiency Immune-mediated myositis Acute lymphocytic leukaemia Dedifferentiated liposarcoma Tourette's disorder Neuromyelitis optica spectrum disorder Non-renal cell carcinoma of kidney Cystic fibrosis lung Chronic graft versus host disease in skin Breast cancer metastatic Insulinoma More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma recurrent Fabry’s disease – Trials in Disease Cystic fibrosis lung – Trials in Disease Mucopolysaccharidosis – Diagnostics Malignant fibrous histiocytoma – Treatment Rett syndrome – Basic Information Nephroblastoma – Treatment Small intestine leiomyosarcoma – Diagnostics Osteosarcoma Andersen-Tawil syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Azelastine Hydrochloride Imifoplatin Calcium Carbonate Tocotrienol Azd8630 LIPASE RUBIDIUM CHLORIDE Bnt314 Hydroxychloroquine Sulfate CEFTAROLINE FOSAMIL GSKVX000000048110 Ertapenem Sodium Eptacog Alfa (Activated) L-Tyrosine Paliperidone Obefazimod Potato Starch Isis 696844 Eye103 Rifaximin More therapies…

    Learn about Your Condition

    Retinal neovascularisation Axial spondyloarthritis Neuralgia Chronic spontaneous urticaria Post procedural hypotension Cardiac disorder Schizophreniform disorder Neuropathic arthropathy Ureteric cancer Breast angiosarcoma Uveitis Mucosal inflammation Anal abscess Metastatic glioma Adenovirus infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study on the Effect of a New Moisturiser with Paraffin and Liquid Paraffin on Preventing Eczema Relapse in Children

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Eczema
    • Dermatitis atopic
    Investigated Drugs:
    • Liquid Paraffin
    • Methylprednisolone Aceponate
    • Paraffin White Soft
    Germany Sweden

  • Study on Dupilumab Step-Down Strategy for Maintaining Remission in Adults and Adolescents with Atopic Dermatitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Betamethasone Valerate
    • Clobetasol
    • Desonide
    France

  • Study on Long-Term Safety and Efficacy of Tildrakizumab for Adults with Psoriatic Arthritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Tildrakizumab
    Czechia Estonia Germany Italy Poland Slovakia +1

  • Study on the Effectiveness and Safety of HRO350 for Patients with Mild-to-Moderate Psoriasis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Betamethasone Valerate
    • Pehero
    Finland Germany Norway Poland

  • Study on Oral Roflumilast for Treating Chronic Hand Eczema in Adults

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Hand dermatitis
    Investigated Drugs:
    • Roflumilast
    • Placebo
    Denmark

  • Study on Ritlecitinib for Adults and Adolescents with Nonsegmental Vitiligo

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Vitiligo
    Investigated Drugs:
    • Dexamethasone
    Bulgaria Germany Italy Poland Spain
Previous Page
1 … 58 59 60 61 62 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!